SLC2A1 and rheumatoid arthritis: This work developed an effective RA therapeutic agent based on RBA, discovered the functional mechanism of RBA in RA therapy for the first time, and showed that the ERK/HIF-1α/GLUT1 pathway could be a promising RA treatment target.